english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Dulaglutide, exenatide, liraglutide and other GLP-1 receptor agonists: thyroid cancer

Glucarpidase (Voraxaze°) for high-dose methotrexate toxicity

Prescrire's annual review of drug packaging: progress is too slow

R&D costs: secrecy at every level

Conditional marketing authorisation: easier to grant than to revoke

Interdisciplinary collaboration

Daridorexant (Quviviq°) in insomnia

Clinical trials in children: many results go unreported

"Hybrid closed-loop" systems for blood glucose control: another way of delivering intensive insulin therapy

Venlafaxine in the first trimester of pregnancy: possible risk of birth defects, especially cardiac malformations

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90